Useful for predicting CHD in select patients
Research clearly shows that other factors impact most patients’ cholesterol levels
Risk modification may be key
Response team expedites real-time multidisciplinary interventions
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Drug-coated balloons, vascular brachytherapy, refining duration of dual antiplatelet therapy
Evolocumab halves cardiovascular events in exploratory analysis
Takeaways from landmark trial of noninvasive testing strategies in CAD
Cleveland Clinic-led trial is first large randomized study of the combo
Final outcomes report changes treatment paradigm
TAVR an acceptable alternative to surgery in patients at high surgical risk
Advertisement
Advertisement